Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Humble Cardiology Associates
mi
from
Humble, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Humble Cardiology Associates
mi
from
Humble, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Gamma Medical Research Inc.
mi
from
Mission, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Gamma Medical Research Inc.
mi
from
Mission, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
San Antonio Endovascular and Heart Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Utah Cardiology PC
mi
from
Layton, UT
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Utah Cardiology PC
mi
from
Layton, UT
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
University of Vermont Medical Center, Fletcher Allen Health Care
mi
from
Burlington, VT
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
University of Vermont Medical Center, Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Cardiovascular Associates Ltd
mi
from
Virginia Beach, VA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Cardiovascular Associates Ltd
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated:  5/17/2013
Swedish Medical Center
mi
from
Seattle, WA
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization
Status: Enrolling
Updated: 5/17/2013
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Cardiology PC
mi
from
Birmingham, AL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Florida
mi
from
Gainesville, FL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Pepin Heart Institute
mi
from
Tampa, FL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Pepin Heart Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Iowa Heart Center
mi
from
Des Moines, IA
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Iowa Heart Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Johns Hopkins University
mi
from
Baltimore, MD
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Spectrum Health
mi
from
Grand Rapids, MI
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Spectrum Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Michigan Cardiovascular Institute
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Washington University
mi
from
St. Louis, MO
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Montefiore Medical Center
mi
from
Bronx, NY
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Columbia University Medical Center
mi
from
New York, NY
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Summa Health System
mi
from
Akron, OH
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
The Lindner Center at The Christ Hospital
mi
from
Cinncinatti, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
Baylor Healthcare
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
Baylor Healthcare
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  5/29/2013
University of Utah
mi
from
Salt Lake City, UT
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 5/29/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated:  6/11/2013
Drexel University
mi
from
Philadelphia, PA
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated: 6/11/2013
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated:  6/11/2013
San Francisco VA Medical Center
mi
from
San Francisco, CA
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
Status: Enrolling
Updated: 6/11/2013
San Francisco VA Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cangrelor Prasugrel Transition Study
A Study of the Transition From IV Cangrelor to Oral Prasugrel, and Prasugrel to Cangrelor, in Patients With Coronary Artery Disease.
Status: Enrolling
Updated:  6/17/2013
Fletcher Allen Health Care
mi
from
Burlington, VT
Cangrelor Prasugrel Transition Study
A Study of the Transition From IV Cangrelor to Oral Prasugrel, and Prasugrel to Cangrelor, in Patients With Coronary Artery Disease.
Status: Enrolling
Updated: 6/17/2013
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated:  6/24/2013
Medstar Health Research Institute - Washington Hospital Center
mi
from
Washington,
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated: 6/24/2013
Medstar Health Research Institute - Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated:  6/24/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated: 6/24/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated:  6/24/2013
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Equivalency Study of the TEG and CORA Hemostasis Systems
Equivalency Study of the CORA(R) and TEG(R) 5000 Systems
Status: Enrolling
Updated: 6/24/2013
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
An Open-label, Single-sequence Study to Evaluate the Potential CYP 3A4 Pharmacokinetic Interaction of Darapladib (SB-480848) in Healthy Subjects
Status: Enrolling
Updated:  6/27/2013
GSK Investigational Site
mi
from
Bethesda, MD
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
An Open-label, Single-sequence Study to Evaluate the Potential CYP 3A4 Pharmacokinetic Interaction of Darapladib (SB-480848) in Healthy Subjects
Status: Enrolling
Updated: 6/27/2013
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation
Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation
Status: Enrolling
Updated:  6/27/2013
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation
Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation
Status: Enrolling
Updated: 6/27/2013
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64: A Randomized Control Study (The faCTor-64 Study)
Status: Enrolling
Updated:  7/9/2013
Intermountain Healthcare
mi
from
Salt Lake City, UT
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64: A Randomized Control Study (The faCTor-64 Study)
Status: Enrolling
Updated: 7/9/2013
Intermountain Healthcare
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Paclitaxel Reduces Effects of Intimal Hyperplasia
Paclitaxel Reduces Effects of Intimal Hyperplasia Status Post Lower Extremity Revascularization
Status: Enrolling
Updated:  7/16/2013
Sanford Vascular Associates
mi
from
Sioux Falls, SD
Paclitaxel Reduces Effects of Intimal Hyperplasia
Paclitaxel Reduces Effects of Intimal Hyperplasia Status Post Lower Extremity Revascularization
Status: Enrolling
Updated: 7/16/2013
Sanford Vascular Associates
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Uric Acid and Hypertension in African Americans
Uric Acid and Hypertension in African Americans
Status: Enrolling
Updated:  7/18/2013
University of Florida
mi
from
Gainesville, FL
Uric Acid and Hypertension in African Americans
Uric Acid and Hypertension in African Americans
Status: Enrolling
Updated: 7/18/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Typical Daily Experiences, Ischemia and Repolarization in Coronary Artery Disease
Typical Daily Emotions, Ischemia and Repolarization in Coronary Artery Disease
Status: Enrolling
Updated:  7/23/2013
University of Arizona
mi
from
Tucson, AZ
Typical Daily Experiences, Ischemia and Repolarization in Coronary Artery Disease
Typical Daily Emotions, Ischemia and Repolarization in Coronary Artery Disease
Status: Enrolling
Updated: 7/23/2013
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia
Umbilical Cord Blood Stem Cell Injection for Critical Limb Ischemia
Status: Enrolling
Updated:  7/24/2013
Northwestern University
mi
from
Chicago, IL
Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia
Umbilical Cord Blood Stem Cell Injection for Critical Limb Ischemia
Status: Enrolling
Updated: 7/24/2013
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals
Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults
Status: Enrolling
Updated:  7/30/2013
Cholesterol Research Center, Children's Hospital Oakland Research Institute
mi
from
Berkeley, CA
Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals
Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults
Status: Enrolling
Updated: 7/30/2013
Cholesterol Research Center, Children's Hospital Oakland Research Institute
mi
from
Berkeley, CA
Click here to add this to my saved trials
Pilot Study of Using Copeptin to Predict Response to Tolvaptan
Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure
Status: Enrolling
Updated:  7/30/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Pilot Study of Using Copeptin to Predict Response to Tolvaptan
Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure
Status: Enrolling
Updated: 7/30/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease
Status: Enrolling
Updated:  8/7/2013
University of Florida
mi
from
Gainesville, FL
EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease
Status: Enrolling
Updated: 8/7/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated:  8/23/2013
North Country Health Care
mi
from
Flagstaff, AZ
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated: 8/23/2013
North Country Health Care
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated:  8/23/2013
Heartland Health Outreach
mi
from
Chicago, IL
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated: 8/23/2013
Heartland Health Outreach
mi
from
Chicago, IL
Click here to add this to my saved trials
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated:  8/23/2013
Near North Health Service Corporation
mi
from
Chicago, IL
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Status: Enrolling
Updated: 8/23/2013
Near North Health Service Corporation
mi
from
Chicago, IL
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
University of New Mexico
mi
from
Albuquerque, NM
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Vanderbilt University School of Medicine
mi
from
Nashville, TN
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Vanderbilt University School of Medicine
mi
from
Nashville, TN
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
McKay Dee Hospital- Intermountain Healthcare
mi
from
Ogden, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
McKay Dee Hospital- Intermountain Healthcare
mi
from
Ogden, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Primary Children's Hospital
mi
from
Salt Lake City, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
University of Utah
mi
from
Salt Lake City, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated:  8/26/2013
Intermountain Medical Center
mi
from
Sandy, UT
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
Status: Enrolling
Updated: 8/26/2013
Intermountain Medical Center
mi
from
Sandy, UT
Click here to add this to my saved trials